Publikationen

Schwarz T, Ptok J, Damagnez M, Menne C, Alizei ES, Lang-Meli J, Maas M, Habermann D, Hoffmann D, Schulze Zur Wiesch J, Lauer G, Kefalakes H, Cornberg M, Kraft AR, Gliga S, Bock HH, Horn PA, Maini MK, Thimme R, Wedemeyer H, Nattermann J, Heinemann FM, Luedde T, Neumann-Haefelin C, Walker A, Timm J. HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication. J Hepatol. 2024 Nov 11:S0168-8278(24)02705-3. doi: 10.1016/j.jhep.2024.10.047.

Peter L, Walotka L, Ptok J, Meyer C, Schüller D, Schaal H, Müller L. Bioinformatics-Driven Refinement of the Commonly Used TPI Nonsense-Mediated Decay Reporter System. RNA. 2024 Oct 16:rna.080134.124. doi: 10.1261/rna.080134.124.

Andreacchio G, Longo Y, Moreno Mascaraque S, Anandasothy K, Tofan S, Özün E, Wilschrey L, Ptok J, Huynh DT, Luirink J, Drexler I. Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice. Vaccines (Basel). 2024 Aug 22;12(8):944. 

Killer A, Gliga S, Massion P, Ackermann C, De Angelis C, Flasshove C, Freise N, Lübke N, Timm J, Eberhardt KA, Bode J, Jensen BO, Luedde T, Orth HM, Feldt T. Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab. Infection. 2024 Aug 29. doi: 10.1007/s15010-024-02375-x.

Roser P, Brunstein M, Specka M, Timm J, Kühnhold S, Schifano F, Bonnet U, Scherbaum N. Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs. Harm Reduct J. 2024 Aug 28;21(1):160. 

Kurzhals S, Schäfer M, Bonnet U, Isbruch K, Kühnhold S, Timm J, Specka M, Scherbaum N. SARS-CoV-2-Infection in People Addicted to Illegal Drugs - Is There a Protective Effect of Opioid Maintenance Treatment? Pharmacopsychiatry. 2024 Sep;57(5):255-260.

Killer A, Gliga S, Lohr C, Weigel C, Ole Jensen BE, Lübke N, Walker A, Timm J, Bode J, Luedde T, Bock HH. Dynamics of Virological and Clinical Response Parameters of Bulevirtide Treatment for Hepatitis D: Real-World Data. Gastro Hep Adv. 2024 Jan 5;3(3):353-360.

Roesmann F, Müller L, Klaassen K, Heß S, Widera M. Interferon-Regulated Expression of Cellular Splicing Factors Modulates Multiple Levels of HIV-1 Gene Expression and Replication. Viruses. 2024 Jun 11;16(6):938. 

Michon M, Müller-Schiffmann A, Lingappa AF, Yu SF, Du L, Deiter F, Broce S, Mallesh S, Crabtree J, Lingappa UF, Macieik A, Müller L, Ostermann PN, Andrée M, Adams O, Schaal H, Hogan RJ, Tripp RA, Appaiah U, Anand SK, Campi TW, Ford MJ, Reed JC, Lin J, Akintunde O, Copeland K, Nichols C, Petrouski E, Moreira AR, Jiang IT, DeYarman N, Brown I, Lau S, Segal I, Goldsmith D, Hong S, Asundi V, Briggs EM, Phyo NS, Froehlich M, Onisko B, Matlack K, Dey D, Lingappa JR, Prasad DM, Kitaygorodskyy A, Solas D, Boushey H, Greenland J, Pillai S, Lo MK, Montgomery JM, Spiropoulou CF, Korth C, Selvarajah S, Paulvannan K, Lingappa VR. A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex. Open Biol. 2024 Jun;14(6):230363.

Longo Y, Mascaraque SM, Andreacchio G, Werner J, Katahira I, De Marchi E, Pegoraro A, Lebbink RJ, Köhrer K, Petzsch P, Tao R, Di Virgilio F, Adinolfi E, Drexler I. The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation. Front Immunol. 2024 Apr 22;15:1360140.

Rothenburg J, Rink-Baron S, Müller L, Ostermann PN, Fischer JC, Hermsen D, Stegbauer J, Moldenhauer A.Immunoadsorption as a method of antibody donation during the COVID-19 pandemic. Vox Sang. 2024 Aug;119(8):792-800.

Salgado M, Gálvez C, Nijhuis M, Kwon M, Cardozo-Ojeda EF, Badiola J, Gorman MJ, Huyveneers LEP, Urrea V, Bandera A, Jensen BO, Vandekerckhove L, Jurado M, Raj K, Schulze Zur Wiesch J, Bailén R, Eberhard JM, Nabergoj M, Hütter G, Saldaña-Moreno R, Oldford S, Barrett L, Ramirez MLM, Garba S, Gupta RK, Revollo B, Ferra-Coll C, Kuball J, Alter G, Sáez-Cirión A, Diez-Martin JL, Duke ER, Schiffer JT, Wensing A, Martinez-Picado J; IciStem Consortium (Lübke-N). Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study. Lancet HIV. 2024 Jun;11(6):e389-e405. 

Lübke N, Walker A, Obermeier M, Camdereli J, Paluschinski M, Walotka L, Schupp AK, Tometten I, Hauka S, Heger E, Timm J. Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA. J Virol Methods. 2024 Apr 11:114937. 

Nollmann C, Moskorz W, Wimmenauer C, Jäger PS, Cadeddu RP, Timm J, Heinzel T, Haas R. Characterization of CD34⁺ Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol. Cancers (Basel). 2024 Mar 28;16(7):1320.

Appel KS, Nürnberger C, Bahmer T, Förster C, Polidori MC, Kohls M, Kraus T, Hettich-Damm N, Petersen J, Blaschke S, Bröhl I, Butzmann J, Dashti H, Deckert J, Dreher M, Fiedler K, Finke C, Geisler R, Hanses F, Hopff SM, Jensen BO, Konik M, Lehnert K, de Miranda SMN, Mitrov L, Miljukov O, Reese JP, Rohde G, Scherer M, Tausche K, Tebbe JJ, Vehreschild JJ, Voit F, Wagner P, Weigl M, Lemhöfer C; NAPKON Study Group. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON (Timm-J)). Infection. 2024 Apr 8. doi: 10.1007/s15010-024-02226-9.

Xu HC, Pandey P, Ward H, Gorzkiewicz M, Abromavičiūtė D, Tinz C, Müller L, Meyer C, Pandyra AA, Yavas A, Borkhardt A, Esposito I, Lang KS, Lang PA. High-Affinity-Mediated Viral Entry Triggers Innate Affinity Escape Resulting in Type I IFN Resistance and Impaired T Cell Immunity. J Immunol. 2024 Mar 18:ji2300637. 

Röring RJ, Debisarun PA, Botey-Bataller J, Suen TK, Bulut O, Kilic G, Koeken VA, Sarlea A, Bahrar H, Dijkstra H, Lemmers H, Gössling KL, Rüchel N, Ostermann PN, Müller L, Schaal H, Adams O, Borkhardt A, Ariyurek Y, de Meijer EJ, Kloet SL, Ten Oever J, Placek K, Li Y, Netea MG. MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells. J Clin Invest. 2024 Jan 30:e170848.

Kasprzak A, Andresen J, Nachtkamp K, Kündgen A, Schulz F, Strupp C, Kobbe G, MacKenzie C, Timm J, Dietrich S, Gattermann N, Germing U. Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry. Cancers (Basel). 2024 Feb 16;16(4):808.

Brunello G, Wolf V, Kerberger R, Bernhard M, Lübke N, Becker J, Schwarz-Herzke B, Timm J, Becker K. Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial. J Clin Periodontol. 2024 Feb;51(2):158-166. 

Steuwe A, Ljimani A, Andree M, Wienemann T, Lübke N, Walker A, Ole Jensen BE, The Racoon Study Group, Radke KL, Antoch G, Valentin B. Disease Course and Pulmonary Involvement of COVID-19 during the Delta Variant Period in Germany: A Comparative Study of Vaccinated and Unvaccinated Patients at a Tertiary Hospital. Curr Med Imaging. 2024 Feb 26. doi: 10.2174/0115734056282920231212104602. 

Esser PL, Quintanares GHR, Langhans B, Heger E, Böhm M, Jensen BO, Esser S, Lübke N, Fätkenheuer G, Lengauer T, Klein F, Oette M, Rockstroh JK, Boesecke C, Di Cristanziano V, Kaiser R, Pirkl M.J. Torque Teno Virus load is associated with CDC stage and CD4+ cell count in people living with HIV but unrelated to AIDS-defining events and Human Pegivirus load. Infect Dis. 2024 Jan 17:jiae014.